Existing drug alleviates symptoms of a rare genetic syndrome

FHS
May 30, 2024
7:15 pm

A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).

FDA authorizes record number of new devices in 2023

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

January 18, 2024

Parachute Health Launches Integrated Solution of DME Ordering with Prior Authorization

What You Should Know: – Parachute Health, a platform for DME (Durable Medical Equipment) and HME (Home Medical Equipment) ordering, has announced a groundbreaking partnership

June 18, 2024

UC Riverside study uncovers COVID’s Achilles heel

New UC Riverside research has revealed COVID’s Achilles heel -; its dependence on key human proteins for its replication -; which can be used to

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.